Molecular Pathologist

Tempus AI, Inc.; Chicago (IL); On-site; USD 260,000 - 300,000; Full time

Benefits offered by this job

Benefits package

Job summary

Tempus AI, Inc. in Chicago seeks an experienced MD physician specialized in Molecular Genetic Pathology to evaluate NGS sequencing results, review clinical reports, and collaborate with a multidisciplinary team.

The role emphasizes maintaining CLIA/CAP compliance and ensuring accurate interpretation for both clinical and research specimens. The ideal candidate will hold an IL medical license (or be in process), be board certified/eligible in Molecular Genetic Pathology, and possess strong

Qualifications

• MD with current medical license (IL licensure to be obtained prior to start date).
• Board certified/eligible in Molecular Genetic Pathology.
• American Board of Pathology Certification in Anatomic and/or Clinical Pathology.
• Clinical experience with next generation sequencing interpretation.
• Knowledge and/or experience in oncology, cancer immunotherapy, medical immunology and clinical research, preferred.
• Excellent managerial, organizational, reporting and communication skills.
• Experience ensuring compliance of a clinical laboratory to regulatory standards.
• Experience working in a regulated clinical laboratory environment (CLIA/CAP/NYSDOH/QSR).

Responsibilities

• Evaluate NGS sequencing results
• Conduct pathology review (H&E and IHC) for clinical and research specimens
• Participate in clinical report review and delivery
• Collaborate with multi-disciplinary team focused on answering key biological questions
• Work to maintain CLIA/CAP compliance

Skills

Communication

Regulatory compliance

Laboratory management

Clinical collaboration

Education

MD with IL license

Board certification/eligible in Molecular Genetic Pathology

ABP Certification in Anatomic/Clinical Pathology

Job description

Passionate about precision medicine and advancing the healthcare industry? Recent advancements in underlying technology have finally made it possible for AI to impact clinical care in a meaningful way. Tempus' proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.

What you’ll do:

• Evaluate NGS sequencing results
• Conduct pathology review (H&E and IHC) for clinical and research specimens
• Participate in clinical report review and delivery
• Collaborate with multi-disciplinary team focused on answering key biological questions
• Work to maintain CLIA/CAP compliance

Preferred Qualifications:

• MD with current medical license (IL licensure to be obtained prior to start date)
• Board certified/eligible in Molecular Genetic Pathology
• American Board of Pathology Certification in Anatomic and/or Clinical Pathology
• Clinical experience with next generation sequencing interpretation
• Knowledge and/or experience in oncology, cancer immunotherapy, medical immunology and clinical research, preferred
• Excellent managerial, organizational, reporting and communication skills
• Experience ensuring compliance of a clinical laboratory to regulatory standards
• Experience working in a regulated clinical laboratory environment (CLIA/CAP/NYSDOH/QSR)

Illinois Pay Range: $260,000-$300,000 The expected salary range may vary for other locations. Actual salary may vary based on qualifications and experience.

Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.

We are an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

Tempus was founded in August of 2015 by Eric Lefkofsky, after his wife was diagnosed with Breast Cancer. Shortly after he founded the company in an effort to bring the power of technology and artificial intelligence to cancer care, he convinced Ryan Fukushima to join as the company’s first employee. Ryan and Eric began assembling a world class team, focused on building the first version of a platform capable of ingesting real time healthcare data in an effort to personalize diagnostics. We built the platform for oncology and have expanded it to neuropsychiatry, cardiology, infectious disease (through COVID), and radiology. Despite our rapid growth, our mission remains the same—to help make sure patients are on the right drug at the right time, so they can live longer and healthier lives.

We’re looking for people who can change the world. Who question the status quo and don’t shy away from tough problems. For the builders who are never done building and the learners who are never done learning. We’re looking for passionate people with undying curiosity. Those who want to attack one of the most challenging problems mankind has ever faced. Head on.